Cargando…

Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy

STUDY OBJECTIVES: To follow the temporal changes of cerebrospinal fluid (CSF) biomarker levels in narcoleptic patients with unexpected hypocretin level at referral. METHODS: From 2007 to 2015, 170 human leukocyte antigen (HLA) DQB1*06:02-positive patients with primary narcolepsy and definite (n = 15...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopez, Régis, Barateau, Lucie, Evangelista, Elisa, Chenini, Sofiene, Robert, Philippe, Jaussent, Isabelle, Dauvilliers, Yves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806580/ https://www.ncbi.nlm.nih.gov/pubmed/28364477 http://dx.doi.org/10.1093/sleep/zsw010

Ejemplares similares

CSF and serum ferritin levels in narcolepsy type 1 comorbid with restless legs syndrome
por: Barateau, Lucie, et al.
Publicado: (2020)

Cardiac Sympathetic Activity differentiates Idiopathic and Symptomatic Rapid Eye Movement Sleep Behaviour Disorder
por: Barateau, Lucie, et al.
Publicado: (2018)

Blood pressure profile and endothelial function in restless legs syndrome
por: Chenini, Sofiene, et al.
Publicado: (2019)

French Language Online Cognitive Behavioral Therapy for Insomnia Disorder: A Randomized Controlled Trial
por: Lopez, Régis, et al.
Publicado: (2019)

Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy
por: Dauvilliers, Yves A., et al.
Publicado: (2014)

Recent advances in treatment for narcolepsy
por: Barateau, Lucie, et al.
Publicado: (2019)

[18F]Fludeoxyglucose-Positron Emission Tomography Evidence for Cerebral Hypermetabolism in the Awake State in Narcolepsy and Idiopathic Hypersomnia
por: Dauvilliers, Yves, et al.
Publicado: (2017)

Hepcidin and ferritin levels in restless legs syndrome: a case–control study
por: Chenini, Sofiene, et al.
Publicado: (2020)

Increased Immune Complexes of Hypocretin Autoantibodies in Narcolepsy
por: Deloumeau, Aude, et al.
Publicado: (2010)

Cerebrospinal fluid proteomics in recent-onset Narcolepsy type 1 reveals activation of the complement system
por: Ayoub, Ikram, et al.
Publicado: (2023)

Restless legs syndrome and cardiovascular diseases: A case-control study
por: Cholley-Roulleau, Marion, et al.
Publicado: (2017)

Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1
por: van der Hoeven, Adrienne Elisabeth, et al.
Publicado: (2022)

Gut microbiota composition is associated with narcolepsy type 1
por: Lecomte, Alexandre, et al.
Publicado: (2020)

Low Vitamin D in Narcolepsy with Cataplexy
por: Carlander, Bertrand, et al.
Publicado: (2011)

From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid
por: Hirtz, Christophe, et al.
Publicado: (2016)

Non-Dipping Blood Pressure Profile in Narcolepsy with Cataplexy
por: Dauvilliers, Yves, et al.
Publicado: (2012)

Cerebrospinal Fluid Hypocretin and Nightmares in Dementia Syndromes
por: Trotti, Lynn Marie, et al.
Publicado: (2021)

Histamine in murine narcolepsy: What do genetic and immune models tell us?
por: Melzi, Silvia, et al.
Publicado: (2021)

Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy
por: Luo, Guo, et al.
Publicado: (2018)

Absence of NMDA receptor antibodies in the rare association between Type 1 Narcolepsy and Psychosis
por: Dauvilliers, Y., et al.
Publicado: (2016)

HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy
por: Sakai, Noriaki, et al.
Publicado: (2019)

Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases
por: Luo, Guo, et al.
Publicado: (2017)

CD4(+) T-Cell Reactivity to Orexin/Hypocretin in Patients With Narcolepsy Type 1
por: Ramberger, Melanie, et al.
Publicado: (2016)

Correction: Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases
por: Luo, Guo, et al.
Publicado: (2019)

Orexin/Hypocretin and Histamine Cross-Talk on Hypothalamic Neuron Counts in Mice
por: Berteotti, Chiara, et al.
Publicado: (2021)

Executive Control of Attention in Narcolepsy
por: Bayard, Sophie, et al.
Publicado: (2012)

In vivo clonal expansion and phenotypes of hypocretin-specific CD4(+) T cells in narcolepsy patients and controls
por: Jiang, Wei, et al.
Publicado: (2019)

Reward-based behaviors and emotional processing in human with narcolepsy-cataplexy
por: Bayard, Sophie, et al.
Publicado: (2013)

Cerebrospinal Fluid Hypocretin-1 (Orexin-A) Level Fluctuates with Season and Correlates with Day Length
por: Boddum, Kim, et al.
Publicado: (2016)

CD8(+) T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens
por: Pedersen, Natasja Wulff, et al.
Publicado: (2019)

Pre-treatment of blood samples reveal normal blood hypocretin/orexin signal in narcolepsy type 1
por: Ægidius, Helene M, et al.
Publicado: (2021)

Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sjögren’s syndrome
por: Bårdsen, Kjetil, et al.
Publicado: (2019)

Hypocretin-1 measurements in cerebrospinal fluid using radioimmunoassay: within and between assay reliability and limit of quantification
por: van der Hoeven, Adrienne Elisabeth, et al.
Publicado: (2022)

Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning
por: Zhang, Zhongxing, et al.
Publicado: (2018)

Author Correction: In vivo clonal expansion and phenotypes of hypocretin-specific CD4(+) T cells in narcolepsy patients and controls
por: Jiang, Wei, et al.
Publicado: (2020)

Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer’s Disease
por: Schmidt, Frank M., et al.
Publicado: (2013)

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness
por: Omori, Yuki, et al.
Publicado: (2018)

Decreased Cerebrospinal Fluid Orexin-A (Hypocretin-1) Concentrations in Patients after Generalized Convulsive Status Epilepticus
por: Samzadeh, Mojdeh, et al.
Publicado: (2020)

Diurnal fluctuation in the number of hypocretin/orexin and histamine producing: Implication for understanding and treating neuronal loss
por: McGregor, Ronald, et al.
Publicado: (2017)

Differences in Brain Morphological Findings between Narcolepsy with and without Cataplexy
por: Nakamura, Masaki, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_oht3r2fls93k48vrtvls8mlnv8